BrightHeart is a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, with an initial focus on the fetal heart assessment. BrightHeart offers a first of its kind digital screening tool for congenital heart defects - applying AI to facilitate comprehensive and standardized fetal heart assessments during routine anatomy scans.
BrightHeart’s innovative AI technology addresses a critical unmet clinical need, targeting the significant challenge of screening for congenital heart defects (CHDs), the most common type of birth defect. Currently, up to 70% of CHDs cases go undetected during routine prenatal ultrasounds due to the complexity of these exams. BrightHeart’s first offering supports the company’s broader vision to deliver expert level ultrasound care, regardless of resources, setting, or expertise.
BrightHeart’s innovative AI technology addresses a critical unmet clinical need, targeting the significant challenge of screening for congenital heart defects (CHDs), the most common type of birth defect. Currently, up to 70% of CHDs cases go undetected during routine prenatal ultrasounds due to the complexity of these exams. BrightHeart’s first offering supports the company’s broader vision to deliver expert level ultrasound care, regardless of resources, setting, or expertise.